Edition:
India

Evotec AG (EVTG.DE)

EVTG.DE on Xetra

15.07EUR
21 Feb 2018
Change (% chg)

€0.26 (+1.76%)
Prev Close
€14.81
Open
€14.70
Day's High
€15.10
Day's Low
€14.52
Volume
1,088,095
Avg. Vol
2,152,890
52-wk High
€22.50
52-wk Low
€7.06

Select another date:

Mon, Jan 8 2018

BRIEF-Evotec, Apeiron Biologics receive milestone payment from Sanofi

* SAYS ‍EVOTEC AND APEIRON ACHIEVE FIRST MILESTONE IN IMMUNO-ONCOLOGY ALLIANCE WITH SANOFI​

BRIEF-Evotec receives milestone payment from Boehringer Ingelheim​

* SAYS ‍EVOTEC RECEIVES CLINICAL MILESTONE AS PART OF ITS DISCOVERY ALLIANCE WITH BOEHRINGER INGELHEIM

BRIEF-Evotec affirms guidance after 9-month core profit jump

* ‍9M adjusted group EBITDA up 28% to eur 39.3 m (9m 2016: eur 30.6 m)​

BRIEF-Evotec, Tesaro enter partnership on novel immuno-oncology agents

* dgap-news: evotec and tesaro enter strategic partnership to discover novel immuno-oncology agents

BRIEF-Evotec achieves first milestone in neurodegeneration alliance with Celgene​‍​

* ‍Evotec achieves first milestone in neurodegeneration alliance with Celgene​

BRIEF-Evotec receives $5 million milestone in Celgene alliance

* Says ‍announced today that its strategic alliance with celgene has reached a first milestone triggering revenues of $ 5.0 m to evotec, which are recognised in q3 of 2017​ Source text for Eikon: Further company coverage: (Frankfurt newsroom)

BRIEF-Evotec says invests in Exscientia to advance AI-driven drug discovery

* Says Evotec invests in Exscientia to advance AI-driven drug discovery

BRIEF-Evotec: EIB grants Evotec unsecured loan facility of up to EUR 75 mln

* DGAP-NEWS: EUROPEAN INVESTMENT BANK SUPPORTS EVOTEC'S INNOVATE STRATEGY WITH EUR 75 M LOAN

BRIEF-Abivax and Evotec enter into strategic collaboration

* ABIVAX AND EVOTEC ENTER INTO STRATEGIC COLLABORATION TO DEVELOP NOVEL ANTIVIRAL AGENTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: